International Clinical Trial: A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07201922) titled 'A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis' on Sept. 30.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Boehringer Ingelheim

Condition: Familial Pulmonary Fibrosis Interstitial Lung Abnormalities Interstitial Lung Diseases

Intervention: Drug: Nerandomilast

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enrollment: Januar...